This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Wyeth. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Seongeun Cho: Innovator in Monoclonal Antibodies
Introduction
Seongeun Cho is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies.
Latest Patents
Seongeun Cho holds a patent for "Anti-TrkB monoclonal antibodies and uses thereof." This invention provides monoclonal antibodies specifically designed for human TrkB. The antibodies bind and activate human TrkB while being selective, meaning they do not bind or activate human TrkA or human TrkC. Additionally, some of these monoclonal antibodies cross-react with murine TrkB. The patent also encompasses humanized or veneered versions of the antibodies, along with pharmaceutical compositions that include these inventive antibodies. Methods for preparing the antibodies and their applications for treatment, detection, or purification are also detailed in the patent.
Career Highlights
Seongeun Cho is associated with Wyeth, a prominent company in the pharmaceutical industry. His work focuses on innovative solutions that address critical health challenges through advanced antibody technology.
Collaborations
Seongeun Cho has collaborated with notable colleagues, including Ming Diana Qian and Davinder Gill. These partnerships have contributed to the advancement of research and development in their field.
Conclusion
Seongeun Cho's work in monoclonal antibodies represents a significant advancement in biotechnology. His innovative contributions continue to impact the medical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile